Clinical decision-making insights for haematologists and oncologists
pharmaphorum
SEPTEMBER 28, 2020
Clinical trial readouts continue to emerge despite countries’ lockdown policies, providing several decision-making challenges for healthcare professionals such as haematologists and oncologists – also known as haem/oncs. Data from the US cited during the webinar showed a five-year survival rate of 34.2% for the period from 2007-2013.
Let's personalize your content